Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Moxisylyte 40mg tablets |
| BNF code | 0206040AIAAACAC |
| Virtual Therapeutic Moiety | Moxisylyte |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 1 Dec 2003 |
| Previous name | Thymoxamine 40mg tablets |
| Basis of previous name | BAN - British Approved Name |
| Reason for name change | Basis of name changed |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products not Available |
| Non-availability status date | 24 Feb 2022 |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Moxisylyte hydrochloride |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 395901000 |
| Strength value numerator | 40.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tablet.oral |
| Dose Form | |
| Formulation | Oral tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Virtual Medicinal Product Packs | |
| Moxisylyte 40mg tablets 112 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.